AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
about
Candidate genes for COPD: current evidence and researchGenetic influences on cystic fibrosis lung disease severity.Disease-modifying genes and monogenic disorders: experience in cystic fibrosis.Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: a case-cohort study and murine model of acute particulate exposureHypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.Hypoxia, receptor for advanced glycation end products, and cystic fibrosis: a pathway to chronic inflammation?SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma.
P2860
Q26777324-722BC681-2BD5-4701-9F59-A31893812F98Q36785547-A64863E3-1A4F-457A-91CE-BF83701F689DQ38233032-E0AF7A96-55CA-4D7B-84C4-ACFAFD46DF5CQ38541559-26EE8701-8F8E-4ACC-B74B-CB8201B23869Q38748673-19FDB4AF-A656-43B1-B415-F61B62671FF4Q39246681-D4894393-A642-41E2-8459-6945E407BE84Q41571383-6795DD85-DFF5-44AF-A144-E1E0D32A0D14Q44909879-DB068CFC-1791-477F-9492-9D64F940D39AQ45031309-BE6ED14D-192E-4326-944C-5CCF7BF2F8EEQ55325814-C35B8A0E-4009-45A5-9E78-830A616EB520
P2860
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@ast
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@en
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@nl
type
label
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@ast
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@en
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@nl
prefLabel
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@ast
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@en
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@nl
P2093
P2860
P1433
P1476
AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
@en
P2093
Annick Clement
Céline Muselet-Charlier
French C F Modifier Gene Study Investigators
Julie Beucher
Pierre-François Busson
Pierre-Yves Boëlle
P2860
P304
P356
10.1371/JOURNAL.PONE.0041913
P407
P577
2012-07-30T00:00:00Z